Moving Beyond the Challenges of Insomnia: New Opportunities in an Expanding Therapeutic Landscape

A continuing medical education activity provided by NAMCP and AAMCN

This activity is an archive from the live session from the 2023 Spring Managed Care Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from June 1, 2023 to August 1, 2024
 

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.
 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from
Idorsia Pharmaceuticals US

Description:
Insomnia is a sleep disorder which makes it difficult to fall asleep or stay asleep, even when a person has the chance to do so. This can affect a person’s sleep so much that they still feel tired after they wake up. Insomnia can also make patients feel that they are the only one still awake while the rest of the world sleeps. It can sap your energy level, affect your mood, and causes stress with your health, work performance and quality of life. The dangers of insomnia can affect more than just a person’s mood and if not treated properly can lead to other effects such as anxiety, depression, irritability, concentration problems, memory problems, poor immune system function, and reduced reaction time. Many adults experience acute insomnia, which can last for days or weeks and is usually the result of stress or a traumatic event in one’s life. There are some people that experience chronic insomnia which is long term and can last for a month or more. There are 60 million Americans affected by the disease. About 25% of Americans experience acute insomnia each year with around 10% experiencing chronic insomnia.


 Upon completion of this activity, participants will be able to:

  • Evaluate the clinical and economic burden of insomnia in terms of different challenges, adverse event management, and medical interventions

  • Discuss the importance of screening for and diagnosing insomnia

  • Implement personalized treatment plans for current treatment options based on recent clinical evidence

  • Analyze recently approved novel treatments that will achieve optimal outcomes for patients with insomnia

  • Explore the role of managed care professionals in the development of evidence-based clinical protocols

     

Faculty: David N. Neubauer, MD
Associate Professor, Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine

Disclosure:

 (Relevant Financial Relationships with Ineligible Companies in the Last 24 Months):
Dr. Neubauer has served as a consultant for Eisai and Idorsia. His presentation has been reviewed for any bias.
Planning Committee: Bill Williams, MD has no relevant financial relationships with an ineligible company in the last 24 months to disclose.

Jeremy Williams has no relevant financial relationships with an ineligible company in the last 24 months to disclose.

Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships with an ineligible company in the last 24 months to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This activity is supported by an educational grant from
Idorsia Pharmaceuticals US


NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue